Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus
Areez Shafqat, Saleha Abdul Rab, O. Ammar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
Т. Л. Каронова, Ksenia A. Golovatyuk, I. V. Kudryavtsev, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2602-2602
Open Access | Times Cited: 33
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
I. V. Kudryavtsev, N. A. Аrsentieva, Zoia R. Korobova, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1906-1906
Open Access | Times Cited: 31
Neutrophil extracellular traps and long COVID
Areez Shafqat, Mohamed H. Omer, Ibrahem Albalkhi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
Erica Matino, Elena Tavella, Manuela Rizzi, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1285-1285
Open Access | Times Cited: 19
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
Manuela Rizzi, Davide D’Onghia, Stelvio Tonello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7099-7099
Open Access | Times Cited: 15
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
Manuela Rizzi, Stelvio Tonello, Davide D’Onghia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 951-951
Open Access | Times Cited: 13
Advances in mechanical biomarkers
Mar Eroles, Félix Rico
Journal of Molecular Recognition (2023) Vol. 36, Iss. 8
Open Access | Times Cited: 13
SARS-CoV-2 epitopes inform future vaccination strategies
Areez Shafqat, Mohamed H. Omer, Omar Ahmad, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
Aishwarya Jaiswal, Sanah Shrivastav, Hemant R. Kushwaha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Matrix Metalloproteinases in Health and Disease in the Times of COVID-19
Carlos Fernández-Patrón, Eugenio Hardy
Biomolecules (2022) Vol. 12, Iss. 5, pp. 692-692
Open Access | Times Cited: 11
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management
Marina Lugarà, Stefania Tamburrini, Maria Coppola, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1856-1856
Open Access | Times Cited: 10
SARS-CoV-2 in brief: from virus to prevention
Hassan Karami, Zeinab Karimi, Negin Karami
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 6, pp. 394-406
Open Access | Times Cited: 9
The Gut Microbiome of Children during the COVID-19 Pandemic
Mickayla Bacorn, Hector N. Romero-Soto, Shira Levy, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2460-2460
Open Access | Times Cited: 9
COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control
Mateus da Silva Matias Antunes, Fabrícia Heloisa Cavicchioli Sugiyama, Humberto Doriguêtto Gravina, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 5
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
Areez Shafqat, Tarek Ziad Arabi, Belal Nedal Sabbah, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 8
Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil
Felipe Kenji Sudo, Talita P. Pinto, Fernanda G. Q. Barros‐Aragão, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 434-447
Closed Access | Times Cited: 3
Applications of advances in mRNA-based platforms as therapeutics and diagnostics in reproductive technologies
Wjdan S. Bafleh, Haia M. R. Abdulsamad, Sally M. Al-Qaraghuli, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs
Nunzio Iraci, Carmelo Corsaro, Salvatore V. Giofrè, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1060-1060
Open Access | Times Cited: 4
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients
Marianna Napoli, Michele Provenzano, Lilio Hu, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6286-6286
Open Access | Times Cited: 3
Hypochloremia: A Potential Indicator of Poor Outcomes in COVID-19
Orçun Barkay, Faruk Karakeçili
Medicina (2024) Vol. 60, Iss. 9, pp. 1414-1414
Open Access
Association of OAS1 gene polymorphism with the severity of COVID‑19 infection
Noha G. Bader El Din, Rehab I. Moustafa, Enaya Ghaleb, et al.
World Academy of Sciences Journal (2024) Vol. 6, Iss. 6
Open Access
COVID-19 Lung Injury: Unique and Familiar Aspects of Pathophysiology
Stefan Hall, Geraint Berger, Christine Lehmann
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11048-11048
Open Access
Page 1 - Next Page

Scroll to top